Revenue
2014
2015
2016
2017
2018
2019
Glucotrack, Inc. (GCTK)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $208,000 | $43,488 | $589,462 | $611,689 | $143,167 | $59,775 | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $9.8M | $9.5M | $4.7M | $2.0M | $1.8M | $1.5M | $1.6M | $3.0M | $3.2M | $2.9M | $2.3M | $1.8M | $2.0M | $1.9M | $1.8M | $934,056 | $1.0M | — | — | — | — | — | — |
| Operating expenses | $16.1M | $14.5M | $7.1M | $4.4M | $4.0M | $3.1M | $3.7M | $6.6M | $11.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$16.1M | −$14.5M | −$7.1M | −$4.4M | −$4.0M | −$3.1M | $3.5M | −$6.5M | $10.6M | −$5.7M | −$4.7M | −$3.6M | −$3.0M | −$2.8M | −$2.3M | −$1.4M | −$1.2M | — | — | — | — | — | — |
| EBITDAderived | — | — | — | — | −$4.0M | −$3.1M | — | — | — | — | — | — | — | −$2.7M | −$2.3M | −$1.3M | — | — | — | — | — | — | — |
| Net income | −$19.4M | −$22.6M | −$7.1M | −$4.4M | −$4.1M | −$2.7M | $3.5M | −$6.7M | $10.3M | −$5.4M | −$5.8M | $3.0M | −$9.8M | −$2.8M | −$2.4M | −$2.8M | −$1.2M | −$1.5M | −$1.6M | −$1.3M | −$1.1M | −$288,233 | −$350,290 |
| Basic EPSper diluted share | $31.22 | $4,106.00 | $34.18 | $0.29 | $0.26 | -$0.02 | -$0.02 | -$4.74 | -$1.87 | -$1.08 | -$1.15 | $0.37 | -$1.95 | -$0.52 | -$0.46 | -$0.70 | $0.30 | — | — | — | — | — | — |
| Diluted EPSper diluted share | $31.22 | $4,106.00 | $34.18 | $0.29 | $0.26 | $0.19 | -$0.02 | -$4.74 | -$1.87 | -$1.08 | -$1.15 | $0.37 | -$1.95 | -$0.52 | -$0.46 | -$0.70 | $0.30 | — | — | — | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 30, 2024Form 4 | John A. Ballantyne Revocable Living Trust dated 08/01/2017TenPercentOwner | BuyWarrants to Purchase Common Stock · derivative | 59.3K | — | — | 59.3K |
| Jul 30, 2024Form 4 | John A. Ballantyne Revocable Living Trust dated 08/01/2017TenPercentOwner | BuyWarrants to Purchase Common Stock · derivative | 76.2K | — | — | 76.2K |
| Jul 30, 2024Form 4 | John A. Ballantyne Revocable Living Trust dated 08/01/2017TenPercentOwner | BuyWarrants to Purchase Common Stock · derivative | 106.7K | — | — | 106.7K |
| Jul 30, 2024Form 4 | BALLANTYNE JOHNDirector,TenPercentOwner | BuyWarrants to Purchase Common Stock · derivative · indirect | 59.3K | — | — | 59.3K |
| Jul 30, 2024Form 4 | BALLANTYNE JOHNDirector,TenPercentOwner | BuyWarrants to Purchase Common Stock · derivative · indirect | 76.2K | — | — | 76.2K |